1-3 of 3
Sahar Zadeh, BSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Second Cancers after Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Relapsed/Refractory Aggressive Non-Hodgkin’s Lymphoma (NHL).

Tara Seshadri, MBBS, Melania Pintilie, MSc, Richard Tsang, MD, John Kuruvilla, MD, Sahar Zadeh, BSc, Armand Keating, MD, Michael Crump, MD
Journal: Blood
Blood (2007) 110 (11): 1673.
https://doi.org/10.1182/blood.V110.11.1673.1673
Published: 2007
Journal Articles

Age under 40 Does Not Confer Superior Prognosis in Patients with Multiple Myeloma Undergoing Upfront Autologous Stem Cell Transplant Despite High Response Rates.

Parneet K. Cheema, MD, Sahar Zadeh, BSc, Donna Reece, MD, Christine I. Chen, MD, Suzanne Trudel, MD, Vishal Kukreti, MD, Joseph R. Mikhael, MD
Journal: Blood
Blood (2007) 110 (11): 5123.
https://doi.org/10.1182/blood.V110.11.5123.5123
Published: 2007
Journal Articles

Second Autologous Stem Cell Transplant (ASCT) as Salvage Therapy in Patients with Relapsed Multiple Myeloma: Improved Outcomes in Patients with Longer Disease Free Interval after First ASCT.

Joseph R. Mikhael, MD, Sahar Zadeh, BSc, Sara Samiee, MD, Keith Stewart, MD, Christine Chen, MD, Suzanne Trudel, MD, Vishal Kukreti, MD, Norman Franke, MD, Andrew Winter, BScN, Drew Phillips, Donna Reece, MD
Journal: Blood
Blood (2007) 110 (11): 946.
https://doi.org/10.1182/blood.V110.11.946.946
Published: 2007